MCID: TST043
MIFTS: 36

Testicular Seminoma

Categories: Rare diseases, Reproductive diseases

Aliases & Classifications for Testicular Seminoma

MalaCards integrated aliases for Testicular Seminoma:

Name: Testicular Seminoma 53
Testicular Seminomatous Germ Cell Tumor 53
Seminomatous Germ Cell Tumor of Testis 53
Seminoma of Testis 53
Seminoma 73

Classifications:



Summaries for Testicular Seminoma

NIH Rare Diseases : 53 The following summary is from Orphanet, a European reference portal for information on rare diseases and orphan drugs.Orpha Number: 842Disease definitionTesticular seminomatous germ celltumor is a rare testicular germ cell tumor (see this term), most commonly presenting with a painless mass in the scrotum, with a very high cure rate if caught in the early stages.EpidemiologyAnnual incidence in Europe is 1/62,000 people. It accounts for 40% of testicular cancer cases.Clinical descriptionSeminoma usually presents in males between the ages of 30-40. A painless mass in the scrotum is indicative of disease. A long-standing hydrocele may be noted causing a feeling of heaviness in the testicle. Gynecomastia and back and flank pain are symptoms that are seen in some patients. Relapse after surgery can occur, usually (in 97% of cases) in the high iliac or retroperitoneal lymph nodes. Metastasis, although rare, can occur in some cases, affecting the lungs, liver, bones and central nervous system.EtiologyEtiology is unknown but tumors are thought to arise from an embryonic germ cell leading to testicular intraepithelial neoplasia (the precursor to classical seminoma). Cryptorchidism is a risk factor for the development of testicular seminomatous germ cell tumors.Diagnostic methodsUltrasound usually confirms the presence of a testicular mass. Measurement of tumor markers in blood such as alpha-fetoprotein (AFP), beta human chorionic gonadotropin (BHC) and lactate dehydrogenase (LDH) is needed as it can be useful in cases where the tumor is still very small. Classical seminoma does not secrete AFP and patients with raised levels of this tumor marker are given a diagnosis of non-seminoma. After surgical removal of testicle, histopathological characteristics are analyzed and a stage can be assigned. In stage 1 disease the primary tumor is limited to the testis and epididymus with possible invasion of the tunica albuginea, tunica vaginalis, spermatic cord and scrotum but no lymph node or distant metastasis. Stage 2 (2A, 2B and 2C) disease features regional lymph node metastasis and stage 3 has distant metastasis of varying degrees.Differential diagnosisTesticular non seminomatous germ cell tumors (see this term) must be excluded.Management and treatmentTreatment for stage 1 seminoma involves an orchiectomy or partial orchiectomy in some cases. Most patients (88%) do not require any further treatment and only surveillance is necessary. In those cases where follow up is difficult, adjuvant carboplatin or radiotherapy can be applied. Para-aortic and ipsilateral iliac radiotherapy (30 Gy in 2 Gy fractions) is the standard treatment of stage 2A seminoma. Cisplatin, etoposide and bleomycin (PEB) chemotherapy (three cycles) or cisplatin and etoposide (PE) chemotherapy (4 cycles) is an alternative to radiotherapy (but has more acute toxicity). Those with stage 2B, 2C and stage 3 seminomas are given PEB chemotherapy (three or four cycles depending on prognosis). In those with a reduced lung capacity or with emphysema or in severe smokers, 4 cycles of PE is preferred over PEB. Ifosfamide is given instead of bleomycin in certain cases (i.e. patients with existing lung damage). Follow up and sometimes a PET scan is recommended to monitor for residual lesions. Due to cosmetic and psychological reasons, patients may be offered testicular prostheses after an orchidectomy.PrognosisPrognosis is good but depends on the stage of disease with 5- year survival rates as high as 99% in stage 1 disease. Relapse rates at 5 years depend on risk factors (ex. invasion of the rete testis, tumor size >4cm) present, but is only 12% in those with no risk factors.Visit the Orphanet disease page for more resources.

MalaCards based summary : Testicular Seminoma, also known as testicular seminomatous germ cell tumor, is related to seminoma and teratoma. An important gene associated with Testicular Seminoma is TSPY1 (Testis Specific Protein Y-Linked 1), and among its related pathways/superpathways are Peptide hormone metabolism and Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors. The drugs Lenograstim and Etoposide have been mentioned in the context of this disorder. Affiliated tissues include testis, bone and lymph node.

Related Diseases for Testicular Seminoma

Diseases related to Testicular Seminoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 63)
# Related Disease Score Top Affiliating Genes
1 seminoma 29.9 CGA CGB3 TSPY1
2 teratoma 29.0 CGA CGB3
3 testicular cancer 28.2 CGA CGB3 TSPY1
4 choriocarcinoma 28.1 CGA CGB3
5 tubular variant testicular seminoma 12.1
6 cribriform variant testicular seminoma 12.1
7 pseudoglandular variant testicular seminoma 12.1
8 testicular germ cell tumor 11.4
9 testis seminoma 11.1
10 mediastinitis 10.0
11 germ cells tumors 10.0
12 prostatitis 9.9
13 testicular microlithiasis 9.9
14 burns 9.9
15 persistent mullerian duct syndrome 9.9
16 duodenitis 9.9
17 gynecomastia 9.9
18 aging 9.9
19 myocardial infarction 9.8
20 malignant teratoma 9.8
21 horseshoe kidney 9.8
22 pericarditis 9.8
23 extragonadal seminoma 9.8
24 pulmonary sequestration 9.8
25 leukemia, acute lymphoblastic 9.8
26 endodermal sinus tumor 9.8
27 retroperitoneal fibrosis 9.8
28 membranous nephropathy 9.8
29 hypogonadism 9.8
30 malignant peripheral nerve sheath tumor 9.8
31 cervicitis 9.8
32 glomerulonephritis 9.8
33 adenocarcinoma 9.8
34 thyroiditis 9.8
35 hepatitis 9.8
36 hepatitis b 9.8
37 astrocytoma 9.8
38 prune belly syndrome 9.8
39 leukemia 9.8
40 grade iii astrocytoma 9.8
41 peritonitis 9.8
42 retinoblastoma 9.8
43 thyroid cancer, nonmedullary, 1 9.8
44 thrombosis 9.8
45 neurofibrosarcoma 9.8
46 adrenocortical carcinoma, hereditary 9.8
47 lymphoblastic leukemia 9.8
48 myeloid sarcoma 9.8
49 sarcoma 9.8
50 brachial plexus neuropathy 9.8

Graphical network of the top 20 diseases related to Testicular Seminoma:



Diseases related to Testicular Seminoma

Symptoms & Phenotypes for Testicular Seminoma

Drugs & Therapeutics for Testicular Seminoma

Drugs for Testicular Seminoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 134)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lenograstim Approved, Investigational Phase 2, Phase 3,Phase 3,Phase 1 135968-09-1
2
Etoposide Approved Phase 2, Phase 3,Phase 3 33419-42-0 36462
3
Cisplatin Approved Phase 2, Phase 3,Phase 3,Phase 1 15663-27-1 84093 441203 2767
4
Carboplatin Approved Phase 3,Phase 2,Phase 1 41575-94-4 10339178 498142 38904
5
Mechlorethamine Approved, Investigational Phase 3,Phase 1,Phase 2 51-75-2 4033
6
Ifosfamide Approved Phase 3,Phase 1,Phase 2 3778-73-2 3690
7
Mesna Approved, Investigational Phase 3,Phase 1,Phase 2 3375-50-6 598
8
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 1,Phase 2 50-02-2 5743
9
Paclitaxel Approved, Vet_approved Phase 2, Phase 3,Phase 3,Phase 1 33069-62-4 36314
10
Granisetron Approved, Investigational Phase 3 109889-09-0 3510
11
Bleomycin Approved, Investigational Phase 2, Phase 3,Phase 3 11056-06-7 5360373
12
Ribavirin Approved Phase 3 36791-04-5 37542
13
Captopril Approved Phase 3 62571-86-2 44093
14
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
15
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
16
Miconazole Approved, Investigational, Vet_approved Phase 3 22916-47-8 4189
17
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
18
Itraconazole Approved, Investigational Phase 3 84625-61-6 55283
19
Ondansetron Approved Phase 3 99614-02-5 4595
20
Palivizumab Approved, Investigational Phase 3 188039-54-5
21
Caspofungin Approved Phase 3 179463-17-3, 162808-62-0 468682 2826718
22
Diphenhydramine Approved, Investigational Phase 3 147-24-0, 58-73-1 3100
23
Promethazine Approved, Investigational Phase 3 60-87-7 4927
24
Vinblastine Approved Phase 3 865-21-4 13342 241903
25 Dexamethasone acetate Phase 3,Phase 1,Phase 2 1177-87-3
26
Isophosphamide mustard Phase 3,Phase 1,Phase 2 0
27 Alkylating Agents Phase 3,Phase 1,Phase 2
28 glucocorticoids Phase 3,Phase 2,Phase 1
29 Adjuvants, Immunologic Phase 3,Phase 1,Phase 2
30 Albumin-Bound Paclitaxel Phase 2, Phase 3,Phase 3,Phase 1
31 Serotonin Agents Phase 3
32 Serotonin Antagonists Phase 3
33 Gastrointestinal Agents Phase 3,Phase 2
34 Neurotransmitter Agents Phase 3
35 Topoisomerase Inhibitors Phase 2, Phase 3,Phase 3
36 Hormone Antagonists Phase 3,Phase 2,Phase 1
37 Hormones Phase 3,Phase 2,Phase 1
38 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2,Phase 1
39 Peripheral Nervous System Agents Phase 3,Phase 2
40 Anti-Bacterial Agents Phase 2, Phase 3,Phase 3
41 Antibiotics, Antitubercular Phase 2, Phase 3,Phase 3
42 Etoposide phosphate Phase 2, Phase 3,Phase 3
43 Immunosuppressive Agents Phase 3,Phase 1,Phase 2
44 Anti-Infective Agents Phase 3,Phase 1,Phase 2
45 Antiemetics Phase 3,Phase 2
46 Anti-Inflammatory Agents Phase 3,Phase 2,Phase 1
47 BB 1101 Phase 3,Phase 1,Phase 2
48 Antimetabolites Phase 3,Phase 1,Phase 2
49 Antiviral Agents Phase 3,Phase 1,Phase 2
50 Autonomic Agents Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 56)
# Name Status NCT ID Phase Drugs
1 Magnetic Resonance Imaging and Computed Tomography in Patients With Stage I Seminoma of the Testicle Unknown status NCT00589537 Phase 3
2 Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma Unknown status NCT00004219 Phase 3 granisetron hydrochloride;lerisetron
3 Combination Chemotherapy in Treating Men With Germ Cell Cancer Unknown status NCT00003643 Phase 2, Phase 3 cisplatin;etoposide;paclitaxel
4 Radiation Therapy Compared With Chemotherapy in Treating Patients With Stage I Testicular Cancer Completed NCT00003014 Phase 3 carboplatin
5 Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors Completed NCT00002596 Phase 3 carboplatin;cisplatin;cyclophosphamide;etoposide
6 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3 captopril;cyclophosphamide
7 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3 ribavirin
8 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3 fluconazole;itraconazole
9 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
10 Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer Completed NCT00003941 Phase 3 cisplatin;etoposide;ifosfamide
11 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
12 Ondansetron With or Without Dexamethasone to Prevent Vomiting in Patients Receiving Radiation Therapy to the Upper Abdomen Completed NCT00016380 Phase 3 dexamethasone;ondansetron
13 Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer Recruiting NCT02341989 Phase 3 Bleomycin Etoposide and Cisplatin;Carboplatin
14 Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors Recruiting NCT02375204 Phase 3 paclitaxel;ifosfamide;cisplatin;pegylated G-CSF;G-CSF;carboplatin;etoposide phosphate
15 Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell Tumors Terminated NCT00072215 Phase 3 cisplatin;ifosfamide;paclitaxel;vinblastine
16 Proton Radiotherapy for Stage I, IIA, and IIB Seminoma Unknown status NCT01557790 Phase 2
17 PHASE II TRIAL OF THE CYCLIN-DEPEDENT KINASE INHIBITOR PD 0332991 IN PATIENTS WITH CANCER Unknown status NCT01037790 Phase 2 PD-0332991
18 Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors Unknown status NCT00551122 Phase 1, Phase 2 cisplatin;gemcitabine hydrochloride;ifosfamide;paclitaxel
19 High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy Unknown status NCT01172912 Phase 2 carboplatin;cisplatin;dexamethasone;etoposide;ifosfamide
20 ARQ 197 for Subjects With Relapsed or Refractory Germ Cell Tumors Completed NCT01055067 Phase 2 Tivantinib (ARQ 197)
21 Docetaxel in Treating Patients With Recurrent or Refractory Germ Cell Cancer Completed NCT00002903 Phase 2 docetaxel
22 Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors Completed NCT00957905 Phase 2 Alvocidib Hydrochloride;Fluorouracil;Leucovorin Calcium;Oxaliplatin
23 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer Completed NCT00002931 Phase 2 carboplatin;etoposide;ifosfamide;paclitaxel
24 Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors Completed NCT00453232 Phase 2 cisplatin;etoposide
25 Sunitinib in Treating Patients With Metastatic Germ Cell Tumors That Have Relapsed or Not Responded to Treatment Completed NCT00453310 Phase 2 sunitinib malate
26 Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors Completed NCT00470366 Phase 2 cisplatin;ifosfamide;paclitaxel
27 Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors Completed NCT00070096 Phase 2 ixabepilone
28 Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00002673 Phase 2
29 Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00003887 Phase 2
30 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2 beclomethasone dipropionate
31 Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors Completed NCT00004157 Phase 2
32 Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer Completed NCT00003408 Phase 2
33 Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin Completed NCT00423852 Phase 1, Phase 2 carboplatin;ifosfamide;paclitaxel
34 Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases Completed NCT00154388 Phase 2 Imatinib mesylate
35 Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma Recruiting NCT01887340 Phase 2 Carboplatin;Etoposide;Cisplatin
36 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Recruiting NCT02834013 Phase 2
37 Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors Recruiting NCT03158064 Phase 2 Durvalumab;Tremelimumab
38 Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors Recruiting NCT00432094 Phase 2 carboplatin;etoposide;ifosfamide;paclitaxel;thiotepa;Mesna
39 Therapy De-escalation in Seminoma Stage IIA/B Active, not recruiting NCT01593241 Phase 2 Carboplatin
40 Carboplatin AUC-10 for Metastatic Seminoma With IGCCCG Good Prognosis Disease-Therapy Directed by Initial Metabolic Response on PET-CT Active, not recruiting NCT02272816 Phase 2 Carboplatin AUC-10
41 Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer Terminated NCT00042952 Phase 2 imatinib mesylate
42 Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors Terminated NCT01808534 Phase 2 palifosfamide
43 Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer Completed NCT00060372 Phase 1 ipilimumab;therapeutic allogeneic lymphocytes
44 Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors Completed NCT00003107 Phase 1
45 Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors Completed NCT00313599 Phase 1 lapatinib;paclitaxel
46 Analysis of Transposon Control Pathways in Germinal Cancers of the Testicle Unknown status NCT02873793
47 REtrospective Study of TESTIcular CAncer Patients at the University Magdeburg Completed NCT02092740
48 Cardiac Function and Cardiovascular Risk Profile in Testicular Cancer Patients Completed NCT00705094
49 Positron Emission Tomography in Detecting Testicle Cancer Completed NCT00045045 Not Applicable
50 Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation Completed NCT00060021 Not Applicable

Search NIH Clinical Center for Testicular Seminoma

Genetic Tests for Testicular Seminoma

Anatomical Context for Testicular Seminoma

MalaCards organs/tissues related to Testicular Seminoma:

41
Testis, Bone, Lymph Node, Liver, Bone Marrow, Lung, Colon

Publications for Testicular Seminoma

Articles related to Testicular Seminoma:

(show top 50) (show all 231)
# Title Authors Year
1
Superior vena cava obstruction by metastatic mediastinal testicular seminoma. Imaging of collateral pathways during gastrointestinal bleeding scintigraphy with <sup>99m</sup>Tc labeled red blood cells. ( 29636233 )
2018
2
Bilateral synchronous testicular seminoma: A rare presentation of a rare disease. ( 29633802 )
2018
3
Peritoneal Myeloid Sarcoma in a Patient Treated for a Testicular Seminoma. ( 29955031 )
2018
4
Testicular seminoma: Scattered radiation dose to the contralateral testis in the modern era. ( 29306641 )
2018
5
On thin ice: barriers to adoption of surveillance for patients with stage I testicular seminoma. Survey of US radiation oncologists. ( 29522295 )
2018
6
Prognostic factors for relapse in stage I testicular seminoma: tumor size and rete testis invasion revisited. ( 29744734 )
2018
7
Pure Testicular Seminoma with Non-Pathologic Elevation of Alpha Fetoprotein: A Case Series. ( 28668957 )
2017
8
Pure Testicular Seminoma Relapsing Late with Somatic Type Malignancy. ( 28367345 )
2017
9
Testicular Seminoma. ( 28160884 )
2017
10
Testicular Seminoma and Its Mimics: From the Radiologic Pathology Archives. ( 28574809 )
2017
11
Appendix 9: Testicular seminoma and non-seminoma: eUpdate published online 29 June 2017 (www.esmo.org/Guidelines/Genitourinary-Cancers). ( 28881930 )
2017
12
Testicular seminoma: oncologic rationale and role of surgery in treatment. ( 28949942 )
2017
13
Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis. ( 28153774 )
2017
14
Testicular seminoma: Are clinical features and treatment outcomes any different in India? ( 29199728 )
2017
15
Re: Testicular Seminoma Clinical Stage 1: Treatment Outcome on a Routine Care Level. ( 28817914 )
2017
16
Testicular seminoma metastasis to duodenum. Misdiagnosed as primary duodenal tumor. ( 27372029 )
2016
17
Testicular Seminoma With Pseudocyst and Coagulation Necrosis Like Burned-out Tumor: A Case Report. ( 27335779 )
2016
18
mTOR expression in human testicular seminoma. ( 26648340 )
2016
19
Isolated metastasis of testicular seminoma to extralobar pulmonary sequestration. ( 26744493 )
2016
20
Long-term outcomes following post-operative radiotherapy for Stage I/II testicular seminoma - an Australasian single-institution experience. ( 27648280 )
2016
21
The diagnostic yield of fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in recurrent testicular seminoma. ( 28058002 )
2016
22
Testicular seminoma clinical stage 1: treatment outcome on a routine care level. ( 27116691 )
2016
23
Testicular Seminoma Occurring After Kidney Transplantation in a Patient Previously Treated for Teratoma: De Novo Malignancy or Recurrence in a Different Histologic Form? ( 27932163 )
2016
24
Differences in global DNA methylation of testicular seminoma are not associated with changes in histone modifications, clinical prognosis, BRAF mutations or gene expression. ( 27886677 )
2016
25
Colon Obstruction as an Isolated Late Gastrointestinal Metastasis of Testicular Seminoma. ( 27678015 )
2016
26
Analysis of the prognosis of patients with testicular seminoma. ( 26893743 )
2016
27
Coexistence of 2 malignant urogenital neoplasms: a testicular seminoma and adenocarcinoma of the prostate gland in a patient 1 year after kidney transplantation. ( 27243345 )
2016
28
TDRG1 functions in testicular seminoma are dependent on the PI3K/Akt/mTOR signaling pathway. ( 26855590 )
2016
29
Re: Management Trends in Stage I Testicular Seminoma: Impact of Race, Insurance Status, and Treatment Facility. ( 26852980 )
2016
30
Stage II Testicular Seminoma: Patterns of Care and Survival by Treatment Strategy. ( 27146264 )
2016
31
Metachronous testicular seminoma after radiotherapy and chemotherapy: a case report. ( 27184033 )
2016
32
Diffuse type testicular seminoma in a stallion. ( 27818621 )
2016
33
Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma. ( 27339401 )
2016
34
Controversies in the management of clinical stage I testicular seminoma. ( 27123323 )
2016
35
Factor V Leiden mutation triggering four major complications to standard dose cisplatin-chemotherapy for testicular seminoma: a case report. ( 25887618 )
2015
36
Torsion of a Giant Intra-abdominal Testicular Seminoma Presenting as Acute Abdomen. ( 25972647 )
2015
37
Cost analysis of adjuvant management strategies in early stage (stage I) testicular seminoma. ( 25610815 )
2015
38
18F-FDG PET/CT with unusual bone and CNS metastases from testicular seminoma. ( 26005986 )
2015
39
A case of testicular seminoma in persistent Mullerian duct syndrome with transverse testicular ectopia. ( 25504517 )
2015
40
Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy. ( 25982582 )
2015
41
Management of Low-Stage Testicular Seminoma. ( 26216816 )
2015
42
A Torted Ruptured Intra-abdominal Testicular Seminoma Presenting As An Acute Abdomen. ( 27200173 )
2015
43
Inguinal lymphnode metastatic testicular seminoma: A case report and review of literature. ( 26837972 )
2015
44
Radiation therapy for stage IIA and IIB testicular seminoma: peripheral dose calculations and risk assessments. ( 25716274 )
2015
45
Stage 1 Testicular Seminoma: Observation vs Radiotherapy. ( 25791401 )
2015
46
Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology. ( 25605506 )
2015
47
Treatment Trends for Stage I Testicular Seminoma in an Equal-Access Medical System. ( 26794393 )
2015
48
Testicular seminoma with early carcinomatous differentiation. ( 25857511 )
2015
49
Late recurrent testicular seminoma: histological evidence is required. ( 26045025 )
2015
50
Stage 1 Testicular Seminoma: Observation vs Radiotherapy. ( 25791403 )
2015

Variations for Testicular Seminoma

Expression for Testicular Seminoma

Search GEO for disease gene expression data for Testicular Seminoma.

Pathways for Testicular Seminoma

GO Terms for Testicular Seminoma

Biological processes related to Testicular Seminoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 peptide hormone processing GO:0016486 8.62 CGA CGB3

Molecular functions related to Testicular Seminoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 hormone activity GO:0005179 8.62 CGA CGB3

Sources for Testicular Seminoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....